结缔组织病患者胸腹主动脉疾病的治疗
本文系统综述了结缔组织病(CTD)患者胸腹主动脉疾病开放与腔内治疗证据,纳入28项研究。开放修复围术期并发症与死亡率低、分支通畅好、再干预率低;腔内修复内移植物相关并发症显著、二次干预与开放转流需求大。开放修复仍是标准方法,分支支架修复为优选技术,腔内干预可在选择性情况下谨慎使用。
要点
- 开放修复胸腹主动脉瘤在CTD患者中围术期并发症与死亡率低、分支通畅好、再干预率低。
- 腔内修复在CTD患者中内移植物相关并发症显著,二次腔内干预和开放转流需求大。
- 开放修复仍是CTD相关主动脉疾病的标准治疗,分支支架修复为优选技术,腔内干预可在选择性情况下谨慎使用。
核心结论
- 缺乏高质量证据支持CTD患者主动脉修复的某一特定方法,开放与腔内修复的对比数据匮乏。
- 腔内干预在CTD患者中与许多器械相关和主动脉相关并发症相关,短期和长期均如此。
- 尽管缺乏1级证据,开放修复目前仍是CTD所致主动脉疾病的标准治疗,分支支架修复尤为优选技术。
- 腔内干预可在选择性情况下谨慎用于CTD患者。
研究设计与样本
- 系统文献综述,检索PubMed及参考文献,纳入28项研究:8项报告开放胸腹主动脉瘤修复结局,8项报告开放分支支架使用,12项报告腔内主动脉修复。
主要发现
- 开放修复报告结局以低围术期并发症与死亡率、良好分支通畅性和低再干预率为特征。
- 腔内修复报告结局以显著的内移植物相关并发症、大量二次腔内干预需求和开放转流为特征。
- 两种修复方法在已发表的随访时长以及急性与择期设置中的使用率存在明显差异。
临床怎么用
- 作者认为,尽管缺乏1级证据,开放修复目前仍是CTD所致主动脉疾病的标准治疗,分支支架修复尤为优选技术。
- 作者认为,腔内干预可在选择性情况下谨慎用于CTD患者。
局限性
- 缺乏高质量证据支持CTD患者主动脉修复的某一特定方法。
- 开放修复与腔内修复之间缺乏对比数据。
- 两种修复方法在已发表的随访时长以及急性与择期设置中的使用率存在明显差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysmal degeneration of the entire aorta is common in patients with connective tissue disorders (CTDs). Potential treatment options of these aneurysms include open repair and endovascular repair. Our objective herein was to review available evidence for different approaches to treatment of thoracoabdominal aortic disease in patients with CTDs. METHODS: We performed a systematic literature review using PubMed and referenced manuscripts on open and endovascular treatment of thoracoabdominal aortic aneurysms and dissections in patients with CTDs. RESULTS: A total of 28 studies were identified for inclusion in this review, 8 reporting on outcomes after open thoracoabdominal aortic aneurysm repair in patients with CTD, 8 on open branched graft use, and 12 on endovascular aortic repair in this population of patients. Reported outcomes were characterized by low perioperative morbidity and mortality, good branch patency, and low rate of reintervention for open repair and significant rates of endograft-related complications and substantial need for secondary endovascular interventions and open conversions for endovascular repair. CONCLUSIONS: There is a lack of high-quality evidence to support any particular approach to aortic repair in patients with CTD and a dearth of comparative data between open repair and endovascular repair. There are distinct differences in the published lengths of follow-up between the two repair approaches as well as in the prevalence of their use in an acute vs elective setting. It is evident that endovascular interventions for aortic disease in patients with CTDs are associated with many device- and aorta-related complications both in the short term and in the long term. Despite the lack of level 1 evidence, open repair currently remains the standard approach to treatment of aortic disease due to CTDs. Open branched graft repair in particular is the preferred technique. Endovascular interventions may be cautiously used in patients with CTDs in selective circumstances.
引用
- Glebova NO, Cameron DE, Black JH, et al. Treatment of thoracoabdominal aortic disease in patients with connective tissue disorders. J Vasc Surg. 2018. PMID: 30244929. doi:10.1016/j.jvs.2018.06.199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。